Blog
MercadoLibre Faces Margin Strain: Should You Hold or Fold the Stock?
MercadoLibre MELI operates e-commerce and fintech platforms across Latin America through its Mercado Libre Marketplace and Mercado Pago services. While the company maintains significant market
July PPI/Core PPI Jumped Unexpectedly
Major economic data is out this morning, and it’s having an impact on trading futures. Inflation metrics and employment tallies — both sides of the Fed’s dual mandate — were represented. As a
Will ARR Surge & Customer Migration Drive CYBR Subscription Revenues?
CyberArk’s CYBR Subscription revenues rebounded after a temporary slowdown in the second and third quarters of 2024. In its second quarter of 2025, CYBR’s subscription revenues came in at $264
UPS Avoids Strike in Multiple States: What's Ahead on the Labor Front?
Avoiding a major labor crisis, at least for the time being, parcel giant United Parcel Service UPS agreed to resolve several outstanding grievances and a local contract dispute. Following the
Can ExxonMobil's Low Carbon Drive Power Its Future?
Exxon Mobil Corporation XOM has integrated its low-carbon strategy into its core operations. It aims for net-zero (Scope 1 & 2) emissions from operated assets (by 2050) and Permian operations (by
Economic Data at 3-Year Highs: PPI, Jobless Claims
Thursday, August 14, 2025Major economic data is out this morning, and it’s having an impact on trading futures. Inflation metrics and employment tallies — both sides of the Fed’s dual mandate — were
CDNS, NVDA Team Up to Advance Billion-Gate AI Design Power Analysis
Cadence Design Systems (CDNS) and NVIDIA Corporation (NVDA) have achieved a breakthrough with hardware-accelerated dynamic power analysis for billion-gate artificial intelligence (AI) designs,
Home Depot Nears Q2 Earnings Release: Is Now the Right Time to Invest?
The Home Depot, Inc. HD is set to report second-quarter fiscal 2025 results on Aug. 19, before market open. The company’s top and bottom lines are expected to have increased year over year in the
RADCOM Q2 Earnings Beat on Robust Top-Line Traction, View Reiterated
RADCOM Ltd. (RDCM) reported second-quarter 2025 non-GAAP earnings per share (EPS) of 25 cents, surpassing the Zacks Consensus Estimate by 13.6%. The bottom line compared favorably with the
Palo Alto Networks' Pre-Q4 Earnings Analysis: Hold or Fold the Stock?
Palo Alto Networks, Inc. PANW is scheduled to report its fourth-quarter fiscal 2025 results on Aug. 18.Palo Alto Networks projects its fiscal fourth-quarter revenues in the range of $2.49-$2.51
Sin Stocks Worth Watching: The Perfect Mix of Growth & Resilience
An updated edition of the June 25, 2025, article.When it comes to stock market investing, many investors gravitate toward companies with a clean, socially responsible image. But there is another
Affirm's Expanded Stripe Partnership to Boost In-Store BNPL
Affirm Holdings, Inc. AFRM has recently expanded its partnership with Stripe to become the first buy now, pay later (“BNPL”) provider to be directly integrated into Stripe Terminal, the
Analysts Estimate VNET Group (VNET) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when VNET Group (VNET) reports results for the quarter ended June 2025. While this widely-known consensus outlook is
SelectQuote (SLQT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when SelectQuote (SLQT) reports results for the quarter ended June 2025. While this widely-known consensus
Bilibili (BILI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Bilibili (BILI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a
Walmart (WMT) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Walmart (WMT) reports results for the quarter ended July 2025. While this widely-known consensus outlook is
Ross Stores (ROST) Expected to Beat Earnings Estimates: Should You Buy?
Ross Stores (ROST) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus outlook gives
Best Momentum Stocks to Buy for August 14th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 14th:
Microvast Holdings, Inc. MVST: This battery technology and energy storage
Cathie Wood's ARK ETFs See Record Investor Rush
After years of outflows and underperformance, Cathie Wood’s ARK ETFs are burning hot, pulling in massive capital. The firm’s 13 U.S.-listed ETFs have gathered $3.7 billion in AUM over the past week
Wall Street Analysts See a 27.66% Upside in Amneal (AMRX): Can the Stock Really Move This High?
Amneal Pharmaceuticals (AMRX) closed the last trading session at $9.4, gaining 13.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Newmark Group (NMRK)'s Technical Outlook is Bright After Key Golden Cross
Newmark Group, Inc. (NMRK) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, NMRK's 50-day simple moving average crossed
Wall Street Analysts Predict an 114.88% Upside in The Beachbody Company (BODI): Here's What You Should Know
Shares of The Beachbody Company, Inc. (BODI) have gained 27.3% over the past four weeks to close the last trading session at $5.04, but there could still be a solid upside left in the stock if
Does Bicara Therapeutics Inc. (BCAX) Have the Potential to Rally 187.73% as Wall Street Analysts Expect?
Shares of Bicara Therapeutics Inc. (BCAX) have gained 5% over the past four weeks to close the last trading session at $11.33, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Predict a 44.79% Upside in Arcutis Biotherapeutics (ARQT): Here's What You Should Know
Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.63, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price



